{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:16:23Z","timestamp":1788952583039,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004872-01"],"award-info":[{"award-number":["1I01BX004872-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004371"],"award-info":[{"award-number":["1I01BX004371"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019697","name":"Universidad Mayor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL142981-01A1"],"award-info":[{"award-number":["1R01HL142981-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.isci.2026.115037","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:11:12Z","timestamp":1771315872000},"page":"115037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic immunometabolic profiling classifies cisplatin sensitivity states using interpretable machine learning"],"prefix":"10.1016","volume":"29","author":[{"given":"Emily Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5748-629X","authenticated-orcid":false,"given":"Diane C.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison Q.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0025-6447","authenticated-orcid":false,"given":"Cheng-Bang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhi","family":"Wangpaichitr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115037_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.isci.2026.115037_bib2","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/0008-5472.CAN-16-1121","article-title":"Ex Vivo Explant Cultures of Non-Small Cell Lung Carcinoma Enable Evaluation of Primary Tumor Responses to Anticancer Therapy","volume":"77","author":"Karekla","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115037_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010140","article-title":"Amino Acid Metabolism in Cancer Drug Resistance","volume":"11","author":"Yoo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.115037_bib4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/0008-5472.CAN-11-1792","article-title":"Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment","volume":"72","author":"Lesokhin","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115037_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030690","article-title":"Comparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo","volume":"12","author":"Hum","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.115037_bib6","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.csbj.2021.07.003","article-title":"Machine learning in the prediction of cancer therapy","volume":"19","author":"Rafique","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.isci.2026.115037_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mdr2.70001","article-title":"Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR","volume":"1","author":"Fang","year":"2025","journal-title":"Med Research"},{"key":"10.1016\/j.isci.2026.115037_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115037_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","article-title":"A Novel Methylation-based Model for Prognostic Prediction in Lung Adenocarcinoma","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.isci.2026.115037_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/2326-6066.CIR-18-0902","article-title":"Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer","volume":"7","author":"Wu","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.115037_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1164\/rccm.201708-1707OC","article-title":"Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer","volume":"198","author":"Yamauchi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2026.115037_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s10238-022-00946-6","article-title":"The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysis","volume":"23","author":"Bronte","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.isci.2026.115037_bib13","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.115037_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105110","article-title":"Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib","volume":"161","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.115037_bib15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41401-020-0400-z","article-title":"Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.115037_bib16","article-title":"The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy","volume":"57","author":"Li","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.isci.2026.115037_bib17","article-title":"The Role of Tumour Metabolism in Cisplatin Resistance","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2026.115037_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2019.03.009","article-title":"Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1\u03b1 in NSCLC which can be overcome by OXPHOS inhibition","volume":"135","author":"Cruz-Berm\u00fadez","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.isci.2026.115037_bib19","first-page":"143","article-title":"Targeting reactive oxygen species to overcome cisplatin resistance in lung cancer","volume":"2","author":"Wangpaichitr","year":"2012","journal-title":"J. Curr. Sci. Technol."},{"key":"10.1016\/j.isci.2026.115037_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115037_bib21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/rccm.201204-0636OC","article-title":"CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer","volume":"186","author":"Feng","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2026.115037_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells13131120","article-title":"Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with Immunotherapy","volume":"13","author":"Knott","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.115037_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.65","article-title":"Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer","volume":"5","author":"Sheen","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.isci.2026.115037_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5306\/wjco.v12.i4.217","article-title":"Oncogenic driver mutations in non-small cell lung cancer: Past, present and future","volume":"12","author":"Chevallier","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.115037_bib25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"Herbst","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115037_bib26","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1158\/0008-5472.CAN-15-1249","article-title":"PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis","volume":"75","author":"Green","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115037_bib27","article-title":"Clinical Significance of PIK3CA Gene in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.isci.2026.115037_bib28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.18632\/oncotarget.2834","article-title":"PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies","volume":"6","author":"Scheffler","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.115037_bib29","article-title":"Methodology of murine lung cancer mimics clinical lung adenocarcinoma progression and metastasis","volume":"15","author":"Kim","year":"2025","journal-title":"Sci. Rep."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226004128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226004128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:45:23Z","timestamp":1788950723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2589004226004128"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115037","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic immunometabolic profiling classifies cisplatin sensitivity states using interpretable machine learning","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115037"}}